Clinical Trial Update: Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial is evaluating oxybutynin extended-release for promoting early continence recovery after robotic prostatectomy; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Prostate Cancer
• Postoperative Urinary Incontinence

Drugs mentioned

• Oxybutynin ER (oxybutynin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Localized Prostate Cancer, Postoperative Urinary Incontinence | NA | Status: RECRUITING